SOAs

23/03/2020

Statement of Advice (SOA): dinutuximab beta (Qarziba) 2632

23/03/2020

Statement of Advice (SOA): eliglustat tartrate (Cerdelga) 2016

24/03/2020

Statement of Advice (SOA): ertugliflozin/metformin (Segluromet) 3492

24/03/2020

Statement of Advice (SOA): etanercept (Enbrel) 1245

24/03/2020

Statement of Advice (SOA): everolimus (Afinitor) 1872

24/03/2020

Statement of Advice (SOA): everolimus (Certican) 1287

24/03/2020

Statement of Advice (SOA): everolimus (Certican) 431

24/03/2020

Statement of Advice (SOA): golimumab (Simponi) 1323

24/03/2020

Statement of Advice (SOA): ibrutinib (imbruvica) 2199

24/03/2020

Statement of Advice (SOA): ibrutinib (Imbruvica) 2027

25/03/2020

Statement of Advice (SOA): idelalisib (Zydelig) 1814

25/03/2020

Statement of Advice (SOA): infliximab (Remicade) 931

25/03/2020

Statement of Advice (SOA): interferon beta-1a (Rebif) 1510

25/03/2020

Statement of Advice (SOA): lenvatinib (Kisplyx) 3290

25/03/2020

Statement of Advice (SOA): lubiprostone (Amitiza) 1910

25/03/2020

Statement of Advice (SOA): naltrexone bupropion (Mysimba) 662

25/03/2020

Statement of Advice (SOA): omalizumab (Xolair) 1047

25/03/2020

Statement of Advice (SOA): panitumumab (Vectibix) 2744

25/03/2020

Statement of Advice (SOA): pemetrexed (Alimta) 1426

27/03/2020

Statement of Advice (SOA): pentosan polysulfate sodium (Elmiron) 3478